US Stock MarketDetailed Quotes

Avenue Therapeutics (ATXI)

Watchlist
  • 0.2775
  • -0.0215-7.19%
15min DelayClose Mar 11 11:13 ET
569.96KMarket Cap-0.02P/E (TTM)

Avenue Therapeutics (ATXI) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/Q2
Stock NameRevenueRatio
Development and commercialization of therapies for the treatment of neurologic diseases1.4M100.00%

By Country/Region

No Data

Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to impact the stock market. Previously, there were indications that Tru Show More